"Primary" dilated hearts.

[1]  Marco Merlo,et al.  Insights into mildly dilated cardiomyopathy: temporal evolution and long‐term prognosis , 2017, European journal of heart failure.

[2]  James A. White,et al.  Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.

[3]  S. Cook,et al.  Truncating Variants in Filamin C: The Challenges of Genotype-Phenotype Correlations in Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[4]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[5]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[6]  J. Kluger,et al.  Late Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy , 2016, Pacing and clinical electrophysiology : PACE.

[7]  Sabino Iliceto,et al.  Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes , 2016, Circulation. Arrhythmia and electrophysiology.

[8]  S. Heymans,et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[9]  S. Iliceto,et al.  Clinical presentation and diagnosis of myocarditis , 2015, Heart.

[10]  A. Kadish,et al.  Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[11]  C. Kramer,et al.  Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis , 2014, Circulation. Cardiovascular imaging.

[12]  P. Elliott.  Classification of cardiomyopathies: evolution or revolution? , 2013, Journal of the American College of Cardiology.

[13]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[14]  G. Bonne,et al.  ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.

[15]  E. Rampersaud,et al.  Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. , 2013, Journal of cardiac failure.

[16]  E. McNally,et al.  Genetic mutations and mechanisms in dilated cardiomyopathy. , 2013, The Journal of clinical investigation.

[17]  A. Angelini,et al.  Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease , 2013, Heart Failure Reviews.

[18]  D. Corrado,et al.  Pathophysiology of arrhythmogenic cardiomyopathy , 2012, Nature Reviews Cardiology.

[19]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[20]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[21]  A. Mansur,et al.  Mutations in the human phospholamban gene in patients with heart failure. , 2011, American heart journal.

[22]  R. Hershberger,et al.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[23]  Ana Morales,et al.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2009, Circulation. Heart failure.

[24]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[25]  P. Rahko,et al.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. , 2008, American heart journal.

[26]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[27]  I. V. Van Gelder,et al.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. , 2007, American heart journal.

[28]  M. Michels,et al.  Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[29]  B. Soliven,et al.  Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[30]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[31]  M. Simpson,et al.  Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy , 2005, Circulation.

[32]  R. Hershberger,et al.  Clinical and genetic issues in familial dilated cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[33]  E. Kranias,et al.  Calcium: Phospholamban: a crucial regulator of cardiac contractility , 2003, Nature Reviews Molecular Cell Biology.

[34]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[35]  Y. Doi,et al.  Long-term prognosis of patients with mildly dilated cardiomyopathy. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[36]  S. Bione,et al.  Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. , 2000, American journal of human genetics.

[37]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[38]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[39]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[40]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[41]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[42]  A. Gavazzi,et al.  The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. SPIC (Italian Multicenter Cardiomyopathy Study) Group. , 1993, American heart journal.

[43]  W. Abelmann,et al.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. , 1992, The American journal of cardiology.

[44]  A. Tajik,et al.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[45]  R L Popp,et al.  Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. , 1990, Circulation.

[46]  Y. Sugishita,et al.  Clinical characteristics of cardiomyopathy with mild dilatation. , 1990, Journal of cardiology.

[47]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[48]  R L Popp,et al.  Mildly dilated congestive cardiomyopathy. , 1985, Circulation.